Past News

No one-size-fits-all artificial intelligence approach works for prevention, diagnosis or treatment using precision medicine

August 18, 2022

A Rutgers analysis of dozens of artificial intelligence (AI) software programs used in precision, or personalized, medicine to prevent, diagnose and treat disease found that no program exists that can be used for all treatments.

No one-size-fits-all artificial intelligence approach works for prevention, diagnosis or treatment using precision medicine

Routine depression screening may capture underdiagnosed patient populations

August 18, 2022

Screening for depression at the primary care level could dramatically increase the likelihood of treatment for those who are traditionally undertreated -- racial and ethnic minority individuals, older adults, those with limited English proficiency and men -- according to a new study.

Routine depression screening may capture underdiagnosed patient populations

New research to reduce harm of gestational diabetes

August 18, 2022

Changing the way gestational diabetes is diagnosed could reduce harms for mothers and babies.

New research to reduce harm of gestational diabetes

Early blood tests predict death, severe disability for traumatic brain injury

August 18, 2022

A study finds that blood tests taken the day of a traumatic brain injury can predict which patients are likely to die or survive with severe disability, allowing clinicians to make decisions earlier on possible treatment of TBI. Higher values of two protein biomarkers, GFAP and UCH-L1, are associated with death and severe injury.

Early blood tests predict death, severe disability for traumatic brain injury

Researchers examine link between pesticides and thyroid cancer risk in Central California area

August 18, 2022

In single pollutant models and within a 20-year period, 10 out of 29 reviewed pesticides were associated with thyroid cancer, including several of the most widely used ones in the U.S. These included paraquat dichloride, glyphosate and oxyfluorfen.

Researchers examine link between pesticides and thyroid cancer risk in Central California area

New dementia risk genes identified through novel testing approach

August 18, 2022

A new study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.

New dementia risk genes identified through novel testing approach

No one-size-fits-all artificial intelligence approach works for prevention, diagnosis or treatment using precision medicine

August 18, 2022

A Rutgers analysis of dozens of artificial intelligence (AI) software programs used in precision, or personalized, medicine to prevent, diagnose and treat disease found that no program exists that can be used for all treatments.

No one-size-fits-all artificial intelligence approach works for prevention, diagnosis or treatment using precision medicine

A warming planet could mess with our sleep -- and make us more vulnerable to infectious disease

August 18, 2022

A warming planet doesn't just mean more people may find it harder to get quality sleep. There is also evidence suggesting that sleep disturbance could make it harder for the body to fend off infection.

A warming planet could mess with our sleep -- and make us more vulnerable to infectious disease

Researchers decipher the mechanism that enables skin cancer to metastasize to the brain -- and inhibited its spread by 80 percent

August 18, 2022

Researchers have deciphered a mechanism that enables skin cancer to metastasize to the brain and managed to delay the spread of the disease by 60% to 80% using existing treatments.

Researchers decipher the mechanism that enables skin cancer to metastasize to the brain -- and inhibited its spread by 80 percent

NIH-funded researchers develop same-day test to detect abnormal fetal chromosomes

August 17, 2022

Scientists funded by the National Institutes of Health have developed a same-day test to identify abnormal fetal chromosomes. The Short-read Transpore Rapid Karyotyping (STORK) test can detect extra or missing chromosomes (i.e., aneuploidy) using samples collected from prenatal tests, such as amniocentesis and chorionic villus sampling, as well as tissue obtained from miscarriage and biopsies from pre-implantation embryos produced using in vitro fertilization (IVF). The study is led by Brynn Levy, Ph.D., and Zev Williams, M.D., Ph.D., from Columbia University Fertility Center and Columbia University Irving Medical Center, New York City, and is supported by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) through the Human Placenta Project.

NIH-funded researchers develop same-day test to detect abnormal fetal chromosomes